Biocept Inc BIOCQ
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.01 / $0.35
- Shares Outstanding
- 2.63M
- Market Cap
- $2.63
- Volume/Avg
- 1,346 / 1,603
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 50
- Website
- https://www.biocept.com
Valuation
Metric | BIOCQ |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
BIOCQ
Financial Strength
Metric | BIOCQ |
|---|---|
Quick Ratio | 1.52 |
Current Ratio | 1.81 |
Interest Coverage | −156.61 |
Quick Ratio
BIOCQ
Profitability
Metric | BIOCQ |
|---|---|
Return on Assets (Normalized) | −78.72% |
Return on Equity (Normalized) | −203.77% |
Return on Invested Capital (Normalized) | −110.09% |
Return on Assets
BIOCQ
Diagnostics & Research Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc TMO | LOCK|M%l$gSty | LOCK|k$K | $257B | |||
| Danaher Corp DHR | LOCK|#y$?!@p | LOCK|d? | $162B | |||
| IDEXX Laboratories Inc IDXX | LOCK|R<m<lN$ | LOCK|yFv | $53B | |||
| Agilent Technologies Inc A | LOCK|?^j#N@& | LOCK|BQj | $49B | |||
| Waters Corp WAT | LOCK|K#Q&^F | LOCK|&Rv | $45B | |||
| IQVIA Holdings Inc IQV | LOCK|FHRpdR! | LOCK|Y!TW^ | $45B | |||
| Mettler-Toledo International Inc MTD | LOCK|&%FxN>B | LOCK|#TGT | $34B | |||
| Illumina Inc ILMN | LOCK|Y<>sKMC | LOCK|>z>t | $32B | |||
| Labcorp Holdings Inc LH | LOCK|SvRFZ!PY | LOCK|MHG# | $30B | |||
| Quest Diagnostics Inc DGX | LOCK|M@Xk#h | LOCK|n?>?j | $28B |
United States